Gain Therapeutics, Inc. (GANX)
1 Item 5.02 filing since 2026-10-28 · roles: CFO. Nasdaq. Pharmaceutical Preparations. State: MD.
| Score | Filed | Event | Role | Person | Seat | Summary |
|---|---|---|---|---|---|---|
| 70 | 2026-10-28 | Appointment | CFO | subscribers | — | Gain Therapeutics, Inc. (GANX): CFO Jeanette Weidner appointed |
Executive changes at other companies: all filings · CEO · CFO · How Item 5.02 works